A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
101
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

argenx